| Liver fibrosis: Direct antifibrotic agents and targeted therapies |
58 |
| Inflammation and fibrosis |
54 |
| The big five in fibrosis: Macrophages, myofibroblasts, matrix, mechanics, and miscommunication |
46 |
| Proteoglycans remodeling in cancer: Underlying molecular mechanisms |
44 |
| Matrix modeling and remodeling: A biological interplay regulating tissue homeostasis and diseases |
42 |
| Targeting TGF-beta signaling for the treatment of fibrosis |
42 |
| Extracellular matrix remodeling and cardiac fibrosis |
39 |
| Thrombospondin-1 regulation of latent TGF-beta activation: A therapeutic target for fibrotic disease |
37 |
| Osteoarthritis as a disease of the cartilage pericellular matrix |
37 |
| Extracellular matrix: The driving force of mammalian diseases |
36 |
| Connective tissue growth factor (CTGF) from basics to clinics |
35 |
| Extracellular matrix in lung development, homeostasis and disease |
32 |
| Extracellular matrix contribution to skin wound re-epithelialization |
32 |
| Cysteine cathepsins in extracellular matrix remodeling: Extracellular matrix degradation and beyond |
31 |
| TSG-6: A multifunctional protein with anti-inflammatory and tissue-protective properties |
31 |
| Renal fibrosis: Primacy of the proximal tubule |
30 |
| Hyaluronan biology: A complex balancing act of structure, function, location and context |
30 |
| Extracellular matrix directs phenotypic heterogeneity of activated fibroblasts |
29 |
| Chemotherapy induces secretion of exosomes loaded with heparanase that degrades extracellular matrix and impacts tumor and host cell behavior |
28 |
| Biomechanical and biomolecular characterization of extracellular matrix structures in human colon carcinomas |
27 |
| Therapeutic approaches to control tissue repair and fibrosis: Extracellular matrix as a game changer |
26 |
| ADAMTS proteins in human disorders |
25 |
| Matrix metalloproteinases and liver fibrosis (translational aspects) |
25 |
| Cartilage diseases |
24 |
| Vascular aspects of the Ehlers-Danlos Syndromes |
23 |
| Endoplasmic reticulum stress in pulmonary fibrosis |
22 |
| Matrix metalloproteinase functions in hepatic injury and fibrosis |
22 |
| Understanding cardiac extracellular matrix remodeling to develop biomarkers of myocardial infarction outcomes |
22 |
| Defective lung function following influenza virus is due to prolonged, reversible hyaluronan synthesis |
22 |
| Idiopathic pulmonary fibrosis: Epithelial-mesenchymal interactions and emerging therapeutic targets |
21 |
| A role for proteoglycans in vascular disease |
20 |
| Proteases and glycosidases on the surface of exosomes: Newly discovered mechanisms for extracellular remodeling |
20 |
| Endothelial cell dysfunction and glycocalyx - A vicious circle |
20 |
| The WNT signaling pathways in wound healing and fibrosis |
20 |
| Extracellular vesicles are integral and functional components of the extracellular matrix |
18 |
| Aging-associated modifications of collagen affect its degradation by matrix metalloproteinases |
18 |
| A novel mouse model of intervertebral disc degeneration shows altered cell fate and matrix homeostasis |
17 |
| Sweet, yet underappreciated: Proteoglycans and extracellular matrix remodeling in heart disease |
17 |
| Fibrotic scarring following lesions to the central nervous system |
16 |
| Molecular and tissue alterations of collagens in fibrosis |
16 |
| Extracellular matrix alterations in senescent cells and their significance in tissue homeostasis |
15 |
| The gelatinases, MMP-2 and MMP- as fine tuners of neuroinflammatory processes |
15 |
| Regulation of fibrosis in muscular dystrophy |
15 |
| Marfan syndrome; A connective tissue disease at the crossroads of mechanotransduction, TGF beta signaling and cell stemness |
15 |
| Biomarkers in idiopathic pulmonary fibrosis |
15 |
| Cartilage oligomeric matrix protein: COMPopathies and beyond |
15 |
| Epidermolysis bullosa: Molecular pathology of connective tissue components in the cutaneous basement membrane zone |
15 |
| Glycosaminoglycan synthesis in the nucleus pulposus: Dysregulation and the pathogenesis of disc degeneration |
14 |
| Elastin in lung development and disease pathogenesis |
14 |
| The heparanase inhibitor PG545 is a potent anti-lymphoma drug: Mode of action |
14 |
